Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Positron Emission Tomography-Computed Tomography
100%
positron emission tomographic scan
41%
Artificial Intelligence
38%
Diseases
31%
Fluorodeoxyglucose F 18
30%
Polyethylene Terephthalate
29%
Metastatic Carcinoma
29%
Oncology
28%
Nuclear Medicine
23%
Neoplasm
23%
Fluorine-18
23%
Computer Assisted Tomography
22%
Fluorodeoxyglucose
18%
Overall Survival
18%
Standardized Uptake Value
17%
Radiology
16%
Prostate Cancer
14%
Malignant Neoplasm
13%
Non Small Cell Lung Cancer
13%
Diagnostic Imaging
13%
Recurrent Disease
12%
Bone Metastasis
12%
Breast Cancer
11%
Radiation Therapy
11%
Inflammatory Breast Cancer
10%
Technetium-99
8%
Bone Cancer
8%
Progression Free Survival
8%
Lung Cancer
8%
Colorectal Carcinoma
8%
Colon Carcinoma
8%
Cancer
8%
Melanoma
8%
Chemoradiotherapy
7%
Circulating Tumor Cell
7%
Radioactive Tracer
7%
Biopsy Technique
6%
Positron Emission Mammography
6%
Bone Scintigraphy
6%
Hazard Ratio
6%
Personalized Medicine
5%
Esophageal Cancer
5%
Magnetic Resonance Imaging
5%
X-Ray Computed Tomography
5%
Positron Emission Tomography - Magnetic Resonance Imaging
5%
Radiopharmaceutical
5%
Lymph Node
5%
Osteosarcoma
5%
Prospective Study
5%
Hodgkin's Lymphoma
5%
Keyphrases
Positron Emission Tomography-computed Tomography (PET-CT)
92%
Positron Emission Tomography
33%
Oncology
26%
Nuclear Medicine
25%
Artificial Intelligence
23%
NCCN Guidelines
22%
Standardized Uptake Value
21%
Metastatic Disease
19%
18F-FDG PET-CT
19%
Clinical Practice Guidelines
18%
SUVmax
18%
Non-small Cell Lung Cancer (NSCLC)
16%
Overall Survival
16%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
14%
Prostate Cancer
14%
Radiologists
13%
Medical Imaging
13%
Bone Metastasis
13%
Computed Tomography
13%
Radium-223
12%
Colorectal Cancer
12%
Chemotherapy
11%
Generative Artificial Intelligence
11%
MiR-223
11%
Tumor
11%
Radiation Therapy
10%
Chemoradiation
10%
Machine Learning Learning
10%
Deep Machine Learning
10%
Fluoride
10%
Inflammatory Breast Cancer
10%
Response Assessment
10%
PET Imaging
9%
Breast Cancer
9%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
8%
Lung Cancer
8%
Colon Cancer
8%
Text-to-image
8%
Skeletal Tumor Burden
8%
Nuclear Imaging
8%
Single Institution
8%
Clinical Utility
8%
Patient Management
8%
Osteosarcoma
7%
Esophageal Cancer
7%
Metastasis
7%
Radiology
7%
18F-fluoride PET
7%
Intelligent Imaging
7%
Progression-free Survival
7%